Predicting and diagnosing TB and CMV in hematopoietic cell transplant recipients
Can ibrutinib be used as a first-line treatment in CLL?
The TK008 Phase III trial on using donor lymphoctyes to treat patients with high-risk acute leukemia
Panel discussion on mantle cell lymphoma
Constantine Tam et al.
FCR or FR – which regimen is better for treating CLL?